Oramed Pharmaceuticals Inc Capital Reinvestment Ratio
Oramed Pharmaceuticals Inc capital reinvestment ratio. Oramed Pharmaceuticals Inc (ORMP) has a Capital Reinvestment Ratio of 0.00x as of June 2024, meaning it reinvests 0% of its operating cash flow ($2.07 Million) in capital expenditures ($17.06). Check cash flow reinvestment rate of Oramed Pharmaceuticals Inc to assess the company's total reinvestment commitment from operating cash flow.
Capital Reinvestment Ratio
Operating Cash Flow
Capital Expenditures
Data as of
Capital Reinvestment Ratio of Oramed Pharmaceuticals Inc (2016–2016)
Capital reinvestment ratio of Oramed Pharmaceuticals Inc from 2016 to 2016. This chart tracks Oramed Pharmaceuticals Inc's Capital Reinvestment Ratio across 1 annual periods. Also explore Oramed Pharmaceuticals Inc (ORMP) equity growth momentum to track the company's year-over-year net asset growth rate.
Oramed Pharmaceuticals Inc Capital Reinvestment Ratio by Year (2016–2016)
Oramed Pharmaceuticals Inc capital reinvestment ratio by year from 2016 to 2016. For the full cash flow conversion analysis, see Oramed Pharmaceuticals Inc (ORMP) cash flow conversion.
| Year | Reinvestment Ratio | Operating CF (USD) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2016 | 0.00x | $4.66 Million | $9.00K | — |